D47.3

Clinical Causes: The exact cause of essential thrombocythemia remains unknown, which is why it is classified as idiopathic. Genetic mutations, such as JAK2, CALR, or MPL gene mutations, are found in many cases and may contribute to the disorder. Environmental factors or previous exposure to certain chemicals might play a role, although more research is needed. It is not inherited, and it primarily affects adults over the age of 50.

Key Symptoms: Ease of bruising or bleeding, including nosebleeds or bleeding gums Small blood clots that may cause pain or swelling, especially in the fingers, toes, or other areas Headaches or dizziness due to increased blood viscosity In rare cases, enlargement of the spleen (splenomegaly) Red or purple patches on the skin caused by bleeding underneath Fatigue or general feeling of illness

Diagnosis Path: Diagnosing essential thrombocythemia involves a combination of blood tests and clinical evaluation. Key diagnostic steps include: - Complete blood count (CBC) showing elevated platelet levels; - Bone marrow biopsy revealing increased megakaryocytes, the cells responsible for producing platelets; - Genetic testing for mutations such as JAK2, CALR, or MPL; - Excluding other causes of high platelet counts, such as inflammatory conditions or iron deficiency; - Monitoring over time to confirm persistent elevated platelet levels.

Treatment Protocols: Management of essential thrombocythemia aims to reduce the risk of clotting or bleeding complications. Treatment options may include: - Low-dose aspirin to prevent blood clots - Medications that suppress bone marrow activity, such as hydroxyurea - Interferon-alpha in certain cases, especially in younger patients - Regular blood tests and clinical assessments to monitor platelet levels - Lifestyle adjustments such as maintaining hydration and avoiding smoking or other clot-promoting factors. It's important to follow medical advice and undergo regular check-ups for optimal disease management.